With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

Rising awareness, innovative therapies, and evolving treatment options drive this growth.

1Department of Medicine, Columbia Center for Human Development, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York. 2Herbert Irving Comprehensive ...

Circulating angiotensinogen (ANG) is synthesized mainly in the liver and cleaved successively by renin and angiotensin-converting enzyme to yield the bioactive peptide angiotensin II (Ang II). Recent ...

management of orthostatic hypertension should be a function mainly of the condition of which it is a feature, and might include adrenergic receptor antagonists ...

In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have gained widespread popularity not only as effective agents in the management of type 2 diabetes but also for their beneficial ...

Introduction: Treatment of type 2 diabetes ... G protein-coupled receptor 5 (TGR5) is a promising antidiabetic target that plays a key role in metabolic regulation, especially in glucose homeostasis ...

alpha and beta 1. Adrenergic receptors present in the mammalian cardiac muscle are now thought to belong to the beta type, and to initiate stimulation when occupied. Isoprenaline 2 is the ...